Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
1
Mins
8 Jun 2017
Diagnosis and Stage-Dependent Treatment of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is currently the second most common cause of cancer-related death worldwide, with the majority of all cases of HCC…
3
Mins
7 Jun 2017
A Cardiologist’s Perspective on Social Media
Like it or hate it, social media, such as Twitter, Facebook, and Instagram, is having an impact on medicine. It is changing the way healthcare providers…
6 Jun 2017
Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting
Oxford, UK and Conshohocken, US, 5 June, 2017 – Immunocore Limited, the world’s leading TCR company developing biological drugs to treat cancer…
5 Jun 2017
F-Star Expands Its Relationship with Merck Through a New Strategic Collaboration to Develop Bispecific Antibodies in Immuno-Oncology
Cambridge, UK, June 04, 2017 – F-star, a biopharmaceutical company developing novel bispecific antibodies, announces today a new partnership with Merck…
5 Jun 2017
Darzalex®▼ (daratumumab) Combination Therapy Improved Clinical Outcomes Regardless of Cytogenetic Risk for Previously-Treated Patients with Multiple Myeloma
Beerse, Belgium, June 4, 2017 – Janssen-Cilag International NV (“Janssen”) today announced new data from updated analyses of the pivotal Phase 3 CASTOR…
5 Jun 2017
Stem Cells Join the Fight Against Arthritis
MODIFIED stem cells derived from mice tails may hold the potential to fight and protect against arthritis, according to the findings of a recent study. A…
5 Jun 2017
New Drug Reduces Effects of Osteoarthritis in Mice
A NEW drug offers hope to osteoarthritis (OA) patients, as researchers have discovered, based on trials conducted with young mice, that senescent cells…
5 Jun 2017
Critical Non-Essentials V’s Marginal Gains Giving the F word to GB Athletes
The first ‘business book’ I remember reading many moons ago was ‘Winning’ by Sir Clive Woodward. I’m not sure how many people would call it a business…
5 Jun 2017
ILC 2017 – Interview – Dr Ahmed Elsharkawy
An interview with Dr Ahmed Elsharkawy (University Hospirals Birmingham, UK) at this year’s ILC congress held in Amsterdam, Netherlands.
5 Jun 2017
ILC 2017 – Opening Ceremony
Our full congress review of ILC 2017 is out now in our Hepatology 5.1 eJournal, and here we give you a look into the opening ceremony.
←
1
2
3
…
838
839
840
841
842
843
844
…
1,029
1,030
1,031
→